References
<A NAME="RG22405ST-1">1</A>
Address: School of Chemistry, University of Manchester, Manchester M60 1QD, UK.
<A NAME="RG22405ST-2A">2a</A>
Temple C.
Rose JD.
Comber RN.
Rener GA.
J. Med. Chem.
1987,
30:
1746
<A NAME="RG22405ST-2B">2b</A>
Cristalli G.
Vittori S.
Eleuteri A.
Grifantini M.
Volpini R.
Lupidi G.
Capolongo L.
Pesenti E.
J. Med. Chem.
1991,
34:
2226
<A NAME="RG22405ST-3A">3a</A>
Cristalli G.
Vittori S.
Eleuteri A.
Volpini R.
Camaioni E.
Lupidi G.
Mohmoud N.
Bevilacqua F.
Palu G.
J. Med. Chem.
1995,
38:
4019
<A NAME="RG22405ST-3B">3b</A>
Cundy DJ.
Holan G.
Otaegui M.
Simpson GW.
Bioorg. Med. Chem. Lett.
1997,
7:
669
<A NAME="RG22405ST-4">4</A>
Temple C.
J. Med. Chem.
1990,
33:
656
<A NAME="RG22405ST-5">5</A>
Bukowski L.
Janowiec M.
Pharmazie
1989,
44:
267
<A NAME="RG22405ST-6">6</A>
Al-Shaar AHM.
Gilmour DW.
Lythgoe DJ.
McClenaghan I.
Ramsden CA.
J. Chem. Soc., Perkin Trans. 1
1992,
2779
<A NAME="RG22405ST-7">7</A>
Penning TD.
Chandrakumar NS.
Desai BN.
Djuric SW.
Gasiecki AF.
Malecha JW.
Miyashiro JM.
Russel MA.
Askonas LJ.
Gierse JK.
Harding EI.
Highkin MK.
Kachur JF.
Kim SH.
Villani-Price D.
Pyla EY.
Ghoreishi-Haack NS.
Smith WG.
Bioorg. Med. Chem. Lett.
2003,
13:
1137
<A NAME="RG22405ST-8A">8a</A>
Alves MJ.
Booth BL.
Freitas AP.
Proença MF.
J. Chem. Soc., Perkin Trans. 1
1992,
913
<A NAME="RG22405ST-8B">8b</A>
Booth BL.
Dias AM.
Proença MF.
J. Chem. Soc., Perkin Trans. 1
1992,
2119
<A NAME="RG22405ST-8C">8c</A>
Alves MJ.
Booth BL.
Proença MF.
J. Heterocycl. Chem.
1994,
31:
345
<A NAME="RG22405ST-8D">8d</A>
Booth BL.
Coster RD.
Proença MF.
Synthesis
1988,
389
<A NAME="RG22405ST-8E">8e</A>
Alves MJ.
Booth BL.
Carvalho MA.
Pritchard RG.
Proença MF.
J. Heterocycl. Chem.
1997,
739
<A NAME="RG22405ST-8F">8f</A>
Al-Azmi A.
Booth BL.
Carpenter RA.
Carvalho MA.
Marrelec E.
Pritchard RG.
Proença MF.
J. Chem. Soc., Perkin Trans. 1
2001,
2532
<A NAME="RG22405ST-8G">8g</A>
Booth BL.
Cabral IM.
Dias AM.
Freitas AP.
Matos-Beja AM.
Proença MF.
Ramos-Silva M.
J. Chem. Soc., Perkin Trans. 1
2001,
1241
<A NAME="RG22405ST-8H">8h</A>
Carvalho MA.
Esteves TM.
Proença MF.
Booth BL.
Org. Biomol. Chem.
2004,
2:
1019
<A NAME="RG22405ST-8I">8i</A>
Carvalho MA.
Álvares Y.
Zaki ME.
Proença MF.
Booth BL.
Org. Biomol. Chem.
2004,
2:
2340
<A NAME="RG22405ST-9A">9a</A>
Dias AM.
Cabral IM.
Proença MF.
Booth BL.
J. Org. Chem.
2002,
67:
5546
<A NAME="RG22405ST-9B">9b</A>
Zaki ME.
Proença MF.
Booth BL.
J. Org. Chem.
2003,
68:
276
<A NAME="RG22405ST-10">10</A>
Compounds 4: a solution of 5-amino-1-aryl-4-cyano-formimidoyl imidazole (0.4-1.2 mmol) in MeCN
(3-5 mL) and DMF (1-3 mL) was combined with methyl cyanoacetate (1.4-2.4 molar equiv)
and the mixture was stirred in an ice bath for 5-8 h. After standing at -10 °C for
1-8 d, the solid suspension was filtered and washed with Et2O. A second crop of the same product could be recovered from the mother liquor after
concentration on the rotary evaporator. The structure of the products obtained was
confirmed by elemental analysis, 1H NMR and 13C NMR spectroscopy. Characterization of 4a: 1H NMR (300 MHz, DMSO-d
6): δ = 8.42 (s, 1 H), 7.69 (d, J = 8.4 Hz, 2 H), 7.32 (d, J = 8.4 Hz, 2 H), 7.20 (s, 4 H), 2.35 (s, 3 H). 13C NMR (75 MHz, DMSO-d
6): δ = 168.14, 151.2, 142.26, 136.34, 132.66, 124.60, 123.61, 118.90, 114.12, 113.52,
92.65, 20.57. Anal. Calcd for C15H9N5O·NH3·1.5 H2O: C, 56.42; H, 4.70; N, 24.33. Found: C, 56.56; H, 4.61; N, 26.08. IR (nujol mull):
2239 (w), 2211 (m), 1598 (m), 1585 (w).
<A NAME="RG22405ST-11">11</A>
Compounds 5: a solution of the ammonium salt of 3-aryl-6,7-dicyano-5-oxo-4,5-dihydro-3H-imidazo[4,5-b]pyridine (ca. 0.35 mmol) in EtOH (3 mL), H2O (5 mL) and AcOH (1-1.5 mL) was stirred at r.t. Turbidity gradually developed and
after 30 min the solid was filtered and washed with EtOH and Et2O. Characterization of 5a: 1H NMR (300 MHz, DMSO-d
6): δ = 13.2-13.8 (br s, 1 H), 8.95 (s, 1 H), 7.65 (d, J = 8.4 Hz, 2 H), 7.42 (d, J = 8.4 Hz, 2 H), 2.40 (s, 3 H). 13C NMR (75 MHz, DMSO-d
6): δ = 162.44, 148.28, 147.54, 138.47, 131.21, 130.25, 129.99, 124.24, 115.12, 114.39,
112.75, 91.16, 20.60. Anal. Calcd for C15H9N5O·0.2 H2O: C, 64.61; H, 3.37; N, 25.13. Found: C, 64.77; H, 3.62; N, 24.76. IR (nujol mull):
2231 (s), 1603 (s), 1576 (m), 1519 (s), 1493 (s).
<A NAME="RG22405ST-12">12</A>
Handbook of Chemistry and Physics
76th ed.:
Lide DR.
CRC Press;
Boca Raton:
1995.
<A NAME="RG22405ST-13">13</A>
Compound 3d: a solution of 5-amino-4-cyanoformimidoyl-(4′-fluorophenyl)imidazole (0.10 g, 0.44
mmol) in MeCN (2 mL) and Et2O (20 mL) was combined with methyl cyanoacetate (0.06 g, 0.60 mmol) while the reaction
mixture was kept stirring in an ice bath. The solution was allowed to stand at -10
°C for 24 h, when the solvent was partially removed in the rotary evaporator. Addition
of EtOH (10 mL) led to an orange solid that was filtered and washed with Et2O to give 3d (0.05 g, 0.16 mmol, 36%). Characterization: 1H NMR (300 MHz, DMSO-d
6): δ = 7.77 (s, 1 H), 7.60 (dd, J = 9.0 Hz, J = 4.8 Hz, 2 H), 7.46 (t, J = 9.0 Hz, 2 H), 7.18 (s, 2 H), 3.77 (s, 3 H). 13C NMR (75 MHz, DMSO-d
6): δ = 162.46 (d, J = 245.0 Hz), 163.01, 148.41, 137.00, 129.14 (d, J = 9.5 Hz), 122.79, 117.01 (d, J = 23.2 Hz), 116.53, 115.27, 52.60. Anal. Calcd for C15H10N2F: C, 57.88; H, 3.24; N, 30.64. Found: C, 57.61; H, 3.55; N, 22.46. IR (nujol mull):
2219 (m), 2202 (m), 1707 (s), 1629 (s), 1541 (s).
<A NAME="RG22405ST-14">14</A>
Calculations were done on an inspection version of Chem3D Ultra 8.0.
<A NAME="RG22405ST-15">15</A>
Gordon AJ.
Ford RA. In The Chemist’s Companion: A Handbook of Practical Data, Techniques and References
John Wiley and Sons;
New York:
1972.
p.62
<A NAME="RG22405ST-16A">16a</A>
Alves MJ.
Booth BL.
Proença MF.
J. Chem. Soc., Perkin Trans. 1
1990,
1705
<A NAME="RG22405ST-16B">16b</A>
Alves MJ.
Booth BL.
Carvalho MA.
Eastwood PR.
Nezhat L.
Pritchard RG.
Proença MF.
J. Chem. Soc., Perkin Trans. 2
1994,
1949
<A NAME="RG22405ST-16C">16c</A>
Beagley B.
Booth BL.
Eastwood PR.
Kieger S.
Pritchard RG.
Alves MJ.
Carvalho MA.
Proença MF.
Acta Crystallogr., Sect. C: Cryst. Struct. Commun.
1995,
49:
1467
<A NAME="RG22405ST-17">17</A>
Tuberculosis Antimicrobial Acquisition & Coordinating Facility, Southern Research
Institute, Birmingham, Alabama, USA.